Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Gatti

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Molecular Sciences|July 14, 2023
Proteome Profiling of the Dura Mater in Patients with Moyamoya AngiopathyTatiana Carrozzini, Giuliana Pollaci, Gemma Gorla, et al.
Cancers|June 2, 2021
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug CombinationsSerena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, et al.
Molecular Genetics & Genomic Medicine|May 3, 2021
RNF213 variant in a patient with Legius syndrome associated with moyamoya syndromeGiulia Romanisio, Cristina Chelleri, Marcello Scala, et al.
Brain : a Journal of Neurology|December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease predictionRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
From cognition to daily functioning: Insights from iatrogenic cerebral amyloid angiopathyGiulia Marinoni, Benedetta Storti, Isabella Canavero, et al.
Biochemical Pharmacology|November 21, 2017
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsCristina Corno, Simone Stucchi, Michelandrea De Cesare, et al.
Biochemical Pharmacology|April 16, 2003
Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma modelsValentina Zuco, Rosanna Supino, Michelandrea De Cesare, et al.
Biochemical Pharmacology|October 8, 2011
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibitionPaola Perego, Giacomo Cossa, Stella Tinelli, et al.
Journal of Clinical Medicine|June 2, 2021
Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?Ignazio G Vetrano, Anna Bersano, Isabella Canavero, et al.
International Journal of Molecular Sciences|January 11, 2022
The Lipid Asset Is Unbalanced in Peripheral Nerve Sheath TumorsIgnazio G Vetrano, Michele Dei Cas, Vittoria Nazzi, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Molecular Sciences|July 14, 2023
Proteome Profiling of the Dura Mater in Patients with Moyamoya AngiopathyTatiana Carrozzini, Giuliana Pollaci, Gemma Gorla, et al.
Cancers|June 2, 2021
Deregulated FASN Expression in BRAF Inhibitor-Resistant Melanoma Cells Unveils New Targets for Drug CombinationsSerena Stamatakos, Giovanni Luca Beretta, Elisabetta Vergani, et al.
Molecular Genetics & Genomic Medicine|May 3, 2021
RNF213 variant in a patient with Legius syndrome associated with moyamoya syndromeGiulia Romanisio, Cristina Chelleri, Marcello Scala, et al.
Brain : a Journal of Neurology|December 19, 2022
Three-tiered EGFr domain risk stratification for individualized NOTCH3-small vessel disease predictionRemco J Hack, Gido Gravesteijn, Minne N Cerfontaine, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 23, 2026
From cognition to daily functioning: Insights from iatrogenic cerebral amyloid angiopathyGiulia Marinoni, Benedetta Storti, Isabella Canavero, et al.
Biochemical Pharmacology|November 21, 2017
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical modelsCristina Corno, Simone Stucchi, Michelandrea De Cesare, et al.
Biochemical Pharmacology|April 16, 2003
Cellular bases of the antitumor activity of a 7-substituted camptothecin in hormone-refractory human prostate carcinoma modelsValentina Zuco, Rosanna Supino, Michelandrea De Cesare, et al.
Biochemical Pharmacology|October 8, 2011
Role of tyrosyl-DNA phosphodiesterase 1 and inter-players in regulation of tumor cell sensitivity to topoisomerase I inhibitionPaola Perego, Giacomo Cossa, Stella Tinelli, et al.
Journal of Clinical Medicine|June 2, 2021
Characteristics of Moyamoya Disease in the Older Population: Is It Possible to Define a Typical Presentation and Optimal Therapeutical Management?Ignazio G Vetrano, Anna Bersano, Isabella Canavero, et al.
International Journal of Molecular Sciences|January 11, 2022
The Lipid Asset Is Unbalanced in Peripheral Nerve Sheath TumorsIgnazio G Vetrano, Michele Dei Cas, Vittoria Nazzi, et al.
Pageof 10